Literature DB >> 20409549

NOS3 gene polymorphisms are associated with risk markers of cardiovascular disease, and interact with omega-3 polyunsaturated fatty acids.

Jane F Ferguson1, Catherine M Phillips, Jolene McMonagle, Pablo Pérez-Martínez, Danielle I Shaw, Julie A Lovegrove, Olfa Helal, Catherine Defoort, Ingrid M F Gjelstad, Christian A Drevon, Ellen E Blaak, Wim H M Saris, Iwona Leszczyńska-Gołabek, Beata Kiec-Wilk, Ulf Risérus, Brita Karlström, Jose Lopez-Miranda, Helen M Roche.   

Abstract

OBJECTIVE: Omega-3 polyunsaturated fatty acids (n-3 PUFA) may protect against the development of cardiovascular disease (CVD). Genotype at key genes such as nitric oxide synthase (NOS3) may determine responsiveness to fatty acids. Gene-nutrient interactions may be important in modulating the development of CVD, particularly in high-risk individuals with the metabolic syndrome (MetS).
METHODS: Biomarkers of CVD risk, plasma fatty acid composition, and NOS3 single nucleotide polymorphism (SNP) genotype (rs11771443, rs1800783, rs1800779, rs1799983, rs3918227, and rs743507) were determined in 450 individuals with the MetS from the LIPGENE dietary intervention cohort. The effect of dietary fat modification for 12 weeks on metabolic indices of the MetS was determined to understand potential NOS3 gene-nutrient interactions.
RESULTS: Several markers of inflammation and dyslipidaemia were significantly different between the genotype groups. A significant gene-nutrient interaction was observed between the NOS3 rs1799983 SNP and plasma n-3 PUFA status on plasma triacylglycerol (TAG) concentrations. Minor allele carriers (AC+AA) showed an inverse association with significantly higher plasma TAG concentrations in those with low plasma n-3 PUFA status and vice versa but the major allele homozygotes (CC) did not. Following n-3 PUFA supplementation, plasma TAG concentrations of minor allele carriers of rs1799983 were considerably more responsive to changes in plasma n-3 PUFA, than major allele homozygotes.
CONCLUSIONS: Carriers of the minor allele at rs1799983 in NOS3 have plasma TAG concentrations which are more responsive to n-3 PUFA. This suggests that these individuals might show greater beneficial effects of n-3 PUFA consumption to reduce plasma TAG concentrations. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20409549     DOI: 10.1016/j.atherosclerosis.2010.03.027

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  19 in total

Review 1.  Nutrigenetics-personalized nutrition in obesity and cardiovascular diseases.

Authors:  Luigi Barrea; Giuseppe Annunziata; Laura Bordoni; Giovanna Muscogiuri; Annamaria Colao; Silvia Savastano
Journal:  Int J Obes Suppl       Date:  2020-07-20

2.  A genetic risk tool for obesity predisposition assessment and personalized nutrition implementation based on macronutrient intake.

Authors:  Leticia Goni; Marta Cuervo; Fermín I Milagro; J Alfredo Martínez
Journal:  Genes Nutr       Date:  2014-11-28       Impact factor: 5.523

3.  N-3 fatty acid supplementation to routine statin treatment inhibits platelet function, decreases patients' daytime blood pressure, and improves inflammatory status.

Authors:  Keren Doenyas-Barak; Sylvia Berman; Ramzia Abu-Hamad; Ahuva Golik; Naomi Rahimi-Levene; Shai Efrati
Journal:  Eur J Clin Pharmacol       Date:  2012-02-25       Impact factor: 2.953

4.  Adipose tissue RNASeq reveals novel gene-nutrient interactions following n-3 PUFA supplementation and evoked inflammation in humans.

Authors:  Jane F Ferguson; Chenyi Xue; Yu Hu; Mingyao Li; Muredach P Reilly
Journal:  J Nutr Biochem       Date:  2016-01-11       Impact factor: 6.048

Review 5.  Nutrigenomics and personalized diets: What will they mean for food?

Authors:  J Bruce German; Angela M Zivkovic; David C Dallas; Jennifer T Smilowitz
Journal:  Annu Rev Food Sci Technol       Date:  2011

6.  Habitual diets rich in dark-green vegetables are associated with an increased response to ω-3 fatty acid supplementation in Americans of African ancestry.

Authors:  Aifric O'Sullivan; Patrice Armstrong; Gertrud U Schuster; Theresa L Pedersen; Hooman Allayee; Charles B Stephensen; John W Newman
Journal:  J Nutr       Date:  2013-11-20       Impact factor: 4.798

7.  Association of nitric oxide synthase 3 gene polymorphism with the risk of type 2 diabetes.

Authors:  Yasaman Garme; Ramin Saravani; Hamid Reza Galavi
Journal:  Biomed Rep       Date:  2017-05-22

8.  Association of Endothelial Nitric Oxide Synthase Gene Polymorphisms with Coronary Artery Disease in North Indian Punjabi Population.

Authors:  Mohd Akbar Bhat; Jatinder Singh; Shiwali Goyal
Journal:  Biochem Genet       Date:  2022-03-08       Impact factor: 1.890

Review 9.  Nutrigenetics and nutrigenomics of atherosclerosis.

Authors:  Aksam J Merched; Lawrence Chan
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

10.  Glu298Asp polymorphism influences the beneficial effects of fish oil fatty acids on postprandial vascular function.

Authors:  Abby K Thompson; Katie J Newens; Kim G Jackson; John Wright; Christine M Williams
Journal:  J Lipid Res       Date:  2012-07-30       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.